VRK1 interacts with p53 forming a basal complex that is activated by UV-induced DNA damage

FEBS Letters

Volumn 588, Issue 5, 2014, Pages 692-700

  López Sánchez, Inmaculada ^a   Valbuena, Alberto ^a   Vázquez Cedeira, Marta ^a,b   Khadake, Jyoti ^c   Sanz García, Marta ^a   Carrillo Jiménez, Alejandro ^a   Lazo, Pedro A ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

DNA damage; Interaction; p53; Phosphorylation; Vaccinia related kinase 1

Indexed keywords

PROTEIN P53; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; VACCINIA RELATED KINASE 1;

ARTICLE; BINDING SITE; CELLULAR STRESS RESPONSE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; ULTRAVIOLET RADIATION;

DNA DAMAGE; INTERACTION; P53; PHOSPHORYLATION; VACCINIA-RELATED KINASE 1;

CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; HEK293 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION, MISSENSE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPS; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 84896708836     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.01.040     Document Type: Article

References (66)

1. K.H. Vousden, and C. Prives Blinded by the light: the growing complexity of p53 Cell 137 2009 413 431
2. D. Menendez, A. Inga, and M.A. Resnick The expanding universe of p53 targets Nat. Rev. Cancer 9 2009 724 737
3. K.H. Vousden, and D.P. Lane P53 in health and disease Nat. Rev. Mol. Cell Biol. 8 2007 275 283
4. S. Polager, and D. Ginsberg P53 and E2f: partners in life and death Nat. Rev. Cancer 9 2009 738 748
5. A.J. Levine, and M. Oren The first 30 years of p53: growing ever more complex Nat. Rev. Cancer 9 2009 749 758
6. D.W. Meek, and C.W. Anderson Posttranslational modification of p53: cooperative integrators of function Cold Spring Harbor Perspect. Biol. 1 2009 a000950
7. S. Lopez-Borges, and P.A. Lazo The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein Oncogene 19 2000 3656 3664
8. F.M. Vega, A. Sevilla, and P.A. Lazo P53 Stabilization and accumulation induced by human vaccinia-related kinase 1 Mol. Cell. Biol. 24 2004 10366 10380
9. A. Valbuena, F.M. Vega, S. Blanco, and P.A. Lazo P53 downregulates its activating vaccinia-related kinase 1, forming a new autoregulatory loop Mol. Cell. Biol. 26 2006 4782 4793
10. P.H. Kussie, S. Gorina, V. Marechal, B. Elenbaas, J. Moreau, A.J. Levine, and N.P. Pavletich Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain Science 274 1996 948 953
11. D.P. Teufel, M. Bycroft, and A.R. Fersht Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2 Oncogene 28 2009 2112 2118
12. O. Schon, A. Friedler, M. Bycroft, S.M. Freund, and A.R. Fersht Molecular mechanism of the interaction between MDM2 and p53 J. Mol. Biol. 323 2002 491 501
13. J.C. Ferreon, C.W. Lee, M. Arai, M.A. Martinez-Yamout, H.J. Dyson, and P.E. Wright Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2 Proc. Natl. Acad. Sci. USA 106 2009 6591 6596
14. C.W. Lee, J.C. Ferreon, A.C. Ferreon, M. Arai, and P.E. Wright Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation Proc. Natl. Acad. Sci. USA 107 2010 19290 19295
15. A. Valbuena, S. Blanco, F.M. Vega, and P.A. Lazo The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53 PLoS ONE 3 2008 e2649
16. R.J. Nichols, and P. Traktman Characterization of three paralogous members of the Mammalian vaccinia related kinase family J. Biol. Chem. 279 2004 7934 7946
17. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934
18. C.F. Cullen, A.L. Brittle, T. Ito, and H. Ohkura The conserved kinase NHK-1 is essential for mitotic progression and unifying acentrosomal meiotic spindles in Drosophila melanogaster J. Cell Biol. 171 2005 593 602
19. M. Gorjanacz, E.P. Klerkx, V. Galy, R. Santarella, C. Lopez-Iglesias, P. Askjaer, and I.W. Mattaj Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly EMBO J. 26 2008 132 143
20. V.A. Belyi, P. Ak, E. Markert, H. Wang, W. Hu, A. Puzio-Kuter, and A.J. Levine The origins and evolution of the p53 family of genes Cold Spring Harbor Perspect. Biol. 2 2010 a001198
21. V. Dötsch, F. Bernassola, D. Coutandin, E. Candi, and G. Melino P63 and p73, the ancestors of p53 Cold Spring Harbor Perspect. Biol. 2 2010 a004887
22. K. Waters, A.Z. Yang, and V. Reinke Genome-wide analysis of germ cell proliferation in C. elegans identifies VRK-1 as a key regulator of CEP-1/p53 Dev. Biol. 344 2010 1011 1025
23. M. Varjosalo et al. Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS Nat. Methods 10 2013 307 314
24. T.H. Kang, D.Y. Park, W. Kim, and K.T. Kim VRK1 phosphorylates CREB and mediates CCND1 expression J. Cell Sci. 121 2008 3035 3041
25. A. Sevilla, C.R. Santos, R. Barcia, F.M. Vega, and P.A. Lazo C-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK) Oncogene 23 2004 8950 8958
26. A. Sevilla, C.R. Santos, F.M. Vega, and P.A. Lazo Human vaccinia-related kinase 1 (VRK1) activates the ATF2 transcriptional activity by novel phosphorylation on Thr-73 and Ser-62 and cooperates with JNK J. Biol. Chem. 279 2004 27458 27465
27. T.H. Kang, D.Y. Park, Y.H. Choi, K.J. Kim, H.S. Yoon, and K.T. Kim Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells Mol. Cell. Biol. 27 2007 8533 8546
28. M. Sanz-Garcia, I. Lopez-Sanchez, and P.A. Lazo Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activities Mol. Cell. Proteomics 7 2008 2199 2214
29. W. Kim et al. Macro histone H2A1.2 (MacroH2A1) protein suppresses mitotic kinase VRK1 during interphase J. Biol. Chem. 287 2012 5278 5289
30. Y.H. Choi, J.K. Lim, M.W. Jeong, and K.T. Kim HnRNP A1 phosphorylated by VRK1 stimulates telomerase and its binding to telomeric DNA sequence Nucleic Acids Res. 40 2012 8499 8518
31. M. Sanz-Garcia, D.M. Monsalve, A. Sevilla, and P.A. Lazo Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage J. Biol. Chem. 287 2012 23757 23768
32. D.W. Meek Tumour suppression by p53: a role for the DNA damage response? Nat. Rev. Cancer 9 2009 714 723
33. A. Valbuena, S. Castro-Obregon, and P.A. Lazo Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway PLoS ONE 6 2011 e17320
34. A. Valbuena, A. Suarez-Gauthier, F. Lopez-Rios, A. Lopez-Encuentra, S. Blanco, P.L. Fernandez, M. Sanchez-Cespedes, and P.A. Lazo Alteration of the VRK1-p53 autoregulatory loop in human lung carcinomas Lung Cancer 58 2007 303 309
35. A. Valbuena, M. Sanz-Garcia, I. Lopez-Sanchez, F.M. Vega, and P.A. Lazo Roles of VRK1 as a new player in the control of biological processes required for cell division Cell. Signal. 23 2011 1267 1272
36. A. Valbuena, I. Lopez-Sanchez, and P.A. Lazo Human VRK1 is an early response gene and its loss causes a block in cell cycle progression PLoS ONE 3 2008 e1642
37. C.R. Santos et al. VRK1 signaling pathway in the context of the proliferation phenotype in head and neck squamous cell carcinoma Mol. Cancer Res. 4 2006 177 185
38. I.J. Kim et al. Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas Nat. Commun. 4 2013 1701
39. T.P. Molitor, and P. Traktman Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo Oncogenesis 2 2013 e48
40. M.S. Wiebe, R.J. Nichols, T.P. Molitor, J.K. Lindgren, and P. Traktman Mice deficient in the serine/threonine protein kinase VRK1 are infertile due to a progressive loss of spermatogonia Biol. Reprod. 82 2010 182 193
41. Y.H. Choi et al. Vaccinia-related kinase 1 is required for the maintenance of undifferentiated spermatogonia in mouse male germ cells PLoS ONE 5 2010 e15254
42. C.S. Schober, F. Aydiner, C.J. Booth, E. Seli, and V. Reinke The kinase VRK1 is required for normal meiotic progression in mammalian oogenesis Mech. Dev. 128 2011 178 190
43. J. Kim, Y.H. Choi, S. Chang, K.T. Kim, and J.H. Je Defective folliculogenesis in female mice lacking Vaccinia-related kinase 1 Sci. Rep. 2 2012 468
44. I. Lopez-Sanchez, M. Sanz-Garcia, and P.A. Lazo Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation Mol. Cell. Biol. 29 2009 1189 1201
45. A. Valbuena, I. Lopez-Sanchez, F.M. Vega, A. Sevilla, M. Sanz-Garcia, S. Blanco, and P.A. Lazo Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations Arch. Biochem. Biophys. 465 2007 219 226
46. M. Sanz-Garcia, M. Vazquez-Cedeira, E. Kellerman, P. Renbaum, E. Levy-Lahad, and P.A. Lazo Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications J. Proteomics 75 2011 548 560
47. R. Barcia, S. Lopez-Borges, F.M. Vega, and P.A. Lazo Kinetic properties of p53 phosphorylation by the human vaccinia-related kinase 1 Arch. Biochem. Biophys. 399 2002 1 5
48. I. Barcia-Sanjurjo, M. Vazquez-Cedeira, R. Barcia, and P.A. Lazo Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals J. Biol. Inorg. Chem. 18 2013 473 482
49. J. Shin et al. NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity J. Biol. Chem. 286 2011 22131 22138
50. P. Renbaum, E. Kellerman, R. Jaron, D. Geiger, R. Segel, M. Lee, M.C. King, and E. Levy-Lahad Spinal muscular atrophy with pontocerebellar hypoplasia is caused by a mutation in the VRK1 gene Am. J. Hum. Genet. 85 2009 281 289
51. A.C. Joerger, and A.R. Fersht The tumor suppressor p53: from structures to drug discovery Cold Spring Harbor Perspect. Biol. 2 2010 a000919
52. T. Soussi, and K.G. Wiman Shaping genetic alterations in human cancer: the p53 mutation paradigm Cancer Cell 12 2007 303 312
53. W.A. Freed-Pastor, and C. Prives Mutant p53: one name, many proteins Genes Dev. 26 2012 1268 1286
54. P. Shannon et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks Genome Res. 13 2003 2498 2504
55. A. Ciccia, and S.J. Elledge The DNA damage response: making it safe to play with knives Mol. Cell 40 2010 179 204
56. S.E. Polo, and S.P. Jackson Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications Genes Dev. 25 2011 409 433
57. D. Crighton et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis Cell 126 2006 121 134
58. P.A. Muller, and K.H. Vousden P53 mutations in cancer Nat. Cell Biol. 15 2013 2 8
59. R. Brosh, and V. Rotter When mutants gain new powers: news from the mutant p53 field Nat. Rev. Cancer 9 2009 701 713
60. M. Oren, and V. Rotter Mutant p53 gain-of-function in cancer Cold Spring Harbor Perspect. Biol. 2 2010 a001107
61. C.R. Coffill et al. Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion EMBO Rep. 13 2012 638 644
62. P.A. Muller et al. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion Oncogene 32 2013 1252 1265
63. W.A. Freed-Pastor et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway Cell 148 2012 244 258
64. H. Song, M. Hollstein, and Y. Xu P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM Nat. Cell Biol. 9 2007 573 580
65. C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain Mol. Cell. Biol. 21 2001 1874 1887
66. S. Strano, S. Dell'Orso, S. Di Agostino, G. Fontemaggi, A. Sacchi, and G. Blandino Mutant p53: an oncogenic transcription factor Oncogene 26 2007 2212 2219